UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, DC
20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A - 16 OR 15D - 16 OF
THE SECURITIES EXCHANGE ACT OF 1934
02 May 2018
Commission
File No. 001-32846
____________________________
CRH
public limited company
(Translation of registrant's name into English)
____________________________
Belgard Castle, Clondalkin,
Dublin 22, Ireland.
(Address of principal executive offices)
____________________________
Indicate
by check mark whether the registrant files or will file annual
reports
under
cover of Form 20-F or Form 40-F:
Form
20-F X Form
40-F___
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by
Regulation
S-T Rule 101(b)(1):_________
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by
Regulation
S-T Rule 101(b)(7):________
Enclosure:
CRH Commences Phase 1 of Share
Buyback Programme
|
Press Release
CRH Commences Phase 1 of Share Buyback Programme
|
On 25 April 2018, CRH plc announced its intention to repurchase
ordinary shares of up to €1 billion over the next 12 months.
As an initial stage of this wider €1 billion programme, CRH
announces that it has entered into arrangements with UBS A.G.,
London Branch (“UBS”) to repurchase ordinary shares on
CRH’s behalf for a maximum consideration of €350
million (the “Phase 1 Programme”).
The Phase 1 Programme will commence today, 2 May 2018, and will end
no later than 22 August 2018.
Under the terms of the Phase 1 Programme, ordinary shares will be
repurchased on the London Stock Exchange. CRH has entered into
non-discretionary instructions with UBS to conduct the Phase 1
Programme on its behalf and to make trading decisions under the
Phase 1 Programme independently of CRH in accordance with certain
pre-set parameters.
The Phase 1 Programme, the purpose of which is to reduce the share
capital of CRH, will be conducted within the limitations of the
authority granted at CRH’s AGM on 26 April 2018 to repurchase
up to 10% of the Company’s ordinary shares in issue (being
84,101,042 ordinary shares), the parameters prescribed by the
Market Abuse Regulation 596/2014, the Commission Delegated
Regulation (EU) 2016/1052 and Chapter 12 of the UK Listing Rules.
The repurchased ordinary shares will be held in treasury pending
their cancellation or re-issue in due course.
This announcement relates solely to the Phase 1 Programme and any
decision in relation to any future buyback programmes will be based
on an ongoing assessment of the capital needs of the business and
general market conditions.
In connection with the buyback programme and the commencement of
the Phase 1 Programme, the Board of Directors has approved the
suspension of the scrip dividend. The scrip dividend offers
shareholders the right to elect to receive an allotment of
additional ordinary shares in respect of all or any part of any
dividend in accordance with Article 137(b) of the Company’s
Articles of Association. The final 2017 dividend to be paid on 4
May 2018 will not be affected by the scrip dividend
suspension.
Contact CRH at Dublin 404 1000 (+353 1 404 1000)
|
Albert
Manifold
|
Chief
Executive
|
|
Senan
Murphy
|
Finance
Director
|
|
Frank
Heisterkamp
|
Head of
Investor Relations
|
Registered Office: No 12965. Registered Office: 42 Fitzwilliam
Square, Dublin 2, R02 R279, Ireland
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
CRH public limited company
|
|
|
(Registrant)
|
|
|
|
|
Date
02 May 2018
|
|
|
|
By:___/s/Neil
Colgan___
|
|
|
N.Colgan
|
|
|
Company Secretary
|